Literature DB >> 20554955

Genome-wide identification of human FOXP3 target genes in natural regulatory T cells.

Timothy J Sadlon1, Bridget G Wilkinson, Stephen Pederson, Cheryl Y Brown, Suzanne Bresatz, Tessa Gargett, Elizabeth L Melville, Kaimen Peng, Richard J D'Andrea, Gary G Glonek, Gregory J Goodall, Heddy Zola, M Frances Shannon, Simon C Barry.   

Abstract

The transcription factor FOXP3 is essential for the formation and function of regulatory T cells (Tregs), and Tregs are essential for maintaining immune homeostasis and tolerance. This is demonstrated by a lethal autoimmune defect in mice lacking Foxp3 and in immunodysregulation polyendocrinopathy enteropathy X-linked syndrome patients. However, little is known about the molecular basis of human FOXP3 function or the relationship between direct and indirect targets of FOXP3 in human Tregs. To investigate this, we have performed a comprehensive genome-wide analysis for human FOXP3 target genes from cord blood Tregs using chromatin immunoprecipitation array profiling and expression profiling. We have identified 5579 human FOXP3 target genes and derived a core Treg gene signature conserved across species using mouse chromatin immunoprecipitation data sets. A total of 739 of the 5579 FOXP3 target genes were differentially regulated in Tregs compared with Th cells, thus allowing the identification of a number of pathways and biological functions overrepresented in Tregs. We have identified gene families including cell surface molecules and microRNAs that are differentially expressed in FOXP3(+) Tregs. In particular, we have identified a novel role for peptidase inhibitor 16, which is expressed on the cell surface of >80% of resting human CD25(+)FOXP3(+) Tregs, suggesting that in conjunction with CD25 peptidase inhibitor 16 may be a surrogate surface marker for Tregs with potential clinical application.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554955     DOI: 10.4049/jimmunol.1000082

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  61 in total

Review 1.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

Review 2.  Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE).

Authors:  Daniel J Raiten; Fayrouz A Sakr Ashour; A Catharine Ross; Simin N Meydani; Harry D Dawson; Charles B Stephensen; Bernard J Brabin; Parminder S Suchdev; Ben van Ommen
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

Review 3.  Bioprinting an Artificial Pancreas for Type 1 Diabetes.

Authors:  Juewan Kim; Kyungwon Kang; Christopher J Drogemuller; Gordon G Wallace; P Toby Coates
Journal:  Curr Diab Rep       Date:  2019-07-04       Impact factor: 4.810

4.  Eosinophils from eosinophilic oesophagitis patients have T cell suppressive capacity and express FOXP3.

Authors:  C Lingblom; J Wallander; M Ingelsten; H Bergquist; M Bove; R Saalman; A Welin; C Wennerås
Journal:  Clin Exp Immunol       Date:  2016-12-06       Impact factor: 4.330

5.  Blunted expression of miR-199a-5p in regulatory T cells of patients with chronic obstructive pulmonary disease compared to unaffected smokers.

Authors:  W M Chatila; G J Criner; W W Hancock; T Akimova; B Moldover; J-K Chang; W Cornwell; M Santerre; T J Rogers
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

6.  MiRNome and transcriptome aided pathway analysis in human regulatory T cells.

Authors:  M H Albert; J Mannert; K K Fleischmann; M Schiemann; P Pagel; I Schmid; T Magg
Journal:  Genes Immun       Date:  2014-05-22       Impact factor: 2.676

Review 7.  The dual role of the X-linked FoxP3 gene in human cancers.

Authors:  Margaret Redpath; Bin Xu; Leon C van Kempen; Alan Spatz
Journal:  Mol Oncol       Date:  2011-03-30       Impact factor: 6.603

8.  Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells.

Authors:  Samik Basu; Britany Hubbard; Ethan M Shevach
Journal:  J Leukoc Biol       Date:  2014-12-09       Impact factor: 4.962

9.  PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation.

Authors:  Zhiyuan Li; Fang Lin; Changhua Zhuo; Guoping Deng; Zuojia Chen; Shuying Yin; Zhimei Gao; Miranda Piccioni; Andy Tsun; Sanjun Cai; Song Guo Zheng; Yu Zhang; Bin Li
Journal:  J Biol Chem       Date:  2014-08-05       Impact factor: 5.157

Review 10.  FOXP3: genetic and epigenetic implications for autoimmunity.

Authors:  Hiroto Katoh; Pan Zheng; Yang Liu
Journal:  J Autoimmun       Date:  2013-01-11       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.